CLINICAL_TRIALS trial_result · 2023-12-11

Clinical Trial Update: JUNIPER: A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF [Phase 2]

Phase 2 trial update for ND-L02-s0201 in idiopathic pulmonary fibrosis has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Nitto Denko Corporation | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2023-12-11